For a more detailed research summary with study citations, see our GHK-Cu copper peptide guide, our collagen and skin regeneration research article, and our anti-ageing peptide research article
Your GP or prescriber should be informed of: All current medicines , including over-the-counter supplements and herbal remedies, to assess potential interactions particularly for medicines with a narrow therapeutic index Any history of liver, kidney, gastrointestinal, or pancreatic conditions , which may influence the safety of lipotropic agents or GLP-1-based therapies Diabetes or pre-diabetes , given the glucose-modulating effects of retatrutide Previous adverse reactions to injectable preparations or weight management treatments The following groups should not use retatrutide or Lipo C injections outside approved clinical trials, and should discuss their options carefully with a clinician: People who are pregnant, breastfeeding, or planning to conceive Adolescents and young people under 18 years of age People with significant hepatic or renal impairment If you are approached by a private clinic offering retatrutide or Lipo C injections, ask for full documentation of the product's regulatory status, the prescriber's qualifications, and the clinical rationale for the proposed treatment plan
Staggered Implementation Rather than starting all peptides simultaneously, staggered implementation allows assessment of individual contributions
Our board-certified doctors and specialists have extensive experience in aesthetic medicine, ensuring that you receive the highest standard of treatment
These act as diluents or vehicles for certain medications that are to be administered via the parenteral route
